Priority Approval/Registration of Drugs Remdesivir and Tocilizumab During the COVID-19 pandemic Ijaz Mustafa COVID-19 June 15, 2020January 18, 2022 Priority-Approval_Registration-of-Drugs-Remdesivir-and-Tocilizumab-During-the-COVID-19-pandemicDownload Share this: Share on LinkedIn (Opens in new window) LinkedIn Share on WhatsApp (Opens in new window) WhatsApp Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X
